Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence
- 532 Downloads
Staphylococcus aureus is a significant cause of human infections globally. Methicillin-resistant S. aureus (MRSA) emerged in the early 1960s and is now endemic in most healthcare facilities. Although healthcare-associated MRSA infections remain a major problem in most industrialized countries, those caused by community-associated MRSA (CA-MRSA) are now the most abundant cause of bacterial infections in the community in some parts of the world, such as the United States. The basis for the emergence and subsequent success of CA-MRSA is incompletely defined. However, the ability of the pathogen to cause disease in otherwise healthy individuals is likely attributed, in part, to its ability to circumvent killing by the innate immune system, which includes survival after phagocytosis by neutrophils. In this review, we discuss the role of neutrophils in host defense against S. aureus and highlight progress made toward understanding mechanisms of CA-MRSA virulence and pathogenesis.
KeywordsNeutrophil Virulence Host defense Staphylococcus aureus CA-MRSA Innate immunity Infection
This article was supported by the Intramural Research Program of the National Institutes of Allergy and Infectious Diseases, National Institutes of Health. The authors thank Anita Mora, NIAID, for help in generating the figure.
Conflict of interest statement
The authors declare no conflict of interest.
- 1.Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M (2001) Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 32(Suppl 2):S114–S132CrossRefPubMedGoogle Scholar
- 5.Spink WW, Hall WH, Ferris V (1945) Clinical significance of staphylococci with natural or acquired resistance to the sulfonamides and to penicillin. JAMA 128:555–559Google Scholar
- 18.Rossney AS, Shore AC, Morgan PM, Fitzgibbon MM, O'Connell B, Coleman DC (2007) The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harboring the Panton–Valentine leukocidin gene (pvl) reveal that pvl is a poor marker for community-acquired MRSA strains in Ireland. J Clin Microbiol 45:2554–2563CrossRefPubMedGoogle Scholar
- 19.Zhang K, McClure JA, Elsayed S, Tan J, Conly JM (2008) Coexistence of Panton–Valentine leukocidin-positive and leukocidin-negative community-associated methicillin-resistant Staphylococcus aureus USA400 sibling strains in a large Canadian health-care region. J Infect Dis 197:195–204CrossRefPubMedGoogle Scholar
- 31.Kennedy AD, Otto M, Braughton KR, Whitney AR, Chen L, Mathema B, Mediavilla JR, Byrne KA, Parkins LD, Tenover FC et al (2008) Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci USA 105:1327–1332CrossRefPubMedGoogle Scholar
- 35.Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, Long RD, Dorward DW, Gardner DJ, Lina G et al (2006) Is Panton–Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194:1761–1770CrossRefPubMedGoogle Scholar
- 36.Diep BA, Stone GG, Basuino L, Graber CJ, Miller A, des Etages S-A, Jones A, Pallazolo-Ballance AM, Perdreau-Remington F, Sensabaugh GF et al (2008) The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis 197:1523–1530CrossRefPubMedGoogle Scholar
- 40.Brown EL, Dumitrescu O, Thomas D, Badiou C, Koers EM, Choudhury P, Vazquez V, Etienne J, Lina G, Vandenesch F et al (2009) The Panton–Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15:156–164CrossRefPubMedGoogle Scholar
- 42.Diep BA, Palazzolo-Ballance AM, Tattevin P, Basuino L, Braughton KR, Whitney AR, Chen L, Kreiswirth BN, Otto M, DeLeo FR et al (2008) Contribution of Panton–Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 3:e3198CrossRefPubMedGoogle Scholar
- 45.Villaruz AE, Bubeck Wardenburg J, Khan BA, Whitney AR, Sturdevant DE, Gardner DJ, DeLeo FR, Otto M (2009) A point mutation in the agr locus rather than expression of the Panton–Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation. J Infect Dis 200:724–734CrossRefPubMedGoogle Scholar
- 47.Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piemont Y, Brousse N, Floret D et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton–Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753–759CrossRefPubMedGoogle Scholar